Hofseth Biocare (Norway) Performance
| HBC Stock | NOK 1.35 0.07 4.93% |
The company retains a Market Volatility (i.e., Beta) of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hofseth Biocare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hofseth Biocare is expected to be smaller as well. At this point, Hofseth Biocare ASA has a negative expected return of -0.34%. Please make sure to check out Hofseth Biocare's treynor ratio, kurtosis, and the relationship between the jensen alpha and potential upside , to decide if Hofseth Biocare ASA performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Hofseth Biocare ASA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in March 2026. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Begin Period Cash Flow | 172.8 M | |
| Total Cashflows From Investing Activities | -37.9 M |
Hofseth |
Hofseth Biocare Relative Risk vs. Return Landscape
If you would invest 177.00 in Hofseth Biocare ASA on November 12, 2025 and sell it today you would lose (42.00) from holding Hofseth Biocare ASA or give up 23.73% of portfolio value over 90 days. Hofseth Biocare ASA is producing return of less than zero assuming 4.8413% volatility of returns over the 90 days investment horizon. Simply put, 43% of all stocks have less volatile historical return distribution than Hofseth Biocare, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Hofseth Biocare Target Price Odds to finish over Current Price
The tendency of Hofseth Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.35 | 90 days | 1.35 | about 76.94 |
Based on a normal probability distribution, the odds of Hofseth Biocare to move above the current price in 90 days from now is about 76.94 (This Hofseth Biocare ASA probability density function shows the probability of Hofseth Stock to fall within a particular range of prices over 90 days) .
Hofseth Biocare Price Density |
| Price |
Predictive Modules for Hofseth Biocare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hofseth Biocare ASA. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hofseth Biocare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hofseth Biocare is not an exception. The market had few large corrections towards the Hofseth Biocare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hofseth Biocare ASA, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hofseth Biocare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.47 | |
β | Beta against Dow Jones | 0.59 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | -0.11 |
Hofseth Biocare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hofseth Biocare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hofseth Biocare ASA can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
Hofseth Biocare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hofseth Stock often depends not only on the future outlook of the current and potential Hofseth Biocare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hofseth Biocare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 357.8 M | |
| Cash And Short Term Investments | 47.2 M |
Hofseth Biocare Fundamentals Growth
Hofseth Stock prices reflect investors' perceptions of the future prospects and financial health of Hofseth Biocare, and Hofseth Biocare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hofseth Stock performance.
| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (1.07) % | |||
| Current Valuation | 1.03 B | |||
| Shares Outstanding | 395.08 M | |||
| Price To Earning | (4.13) X | |||
| Price To Book | 5.19 X | |||
| Price To Sales | 8.29 X | |||
| Revenue | 87.62 M | |||
| EBITDA | (87.72 M) | |||
| Cash And Equivalents | 36.52 M | |||
| Cash Per Share | 0.12 X | |||
| Total Debt | 123.31 M | |||
| Debt To Equity | 188.20 % | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (61.78 M) | |||
| Earnings Per Share | (0.38) X | |||
| Total Asset | 415.97 M | |||
| Retained Earnings | (105 M) | |||
| Current Asset | 52 M | |||
| Current Liabilities | 74 M | |||
About Hofseth Biocare Performance
By examining Hofseth Biocare's fundamental ratios, stakeholders can obtain critical insights into Hofseth Biocare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Hofseth Biocare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Hofseth BioCare ASA, a biotech company, offers value added biomarine ingredients and finished products for human consumption and pet in Norway. The company was founded in 2000 and is headquartered in lesund, Norway. HOFSETH BIOCARE operates under Pharmaceuticals And Biosciences classification in Norway and is traded on Oslo Stock Exchange. It employs 44 people.Things to note about Hofseth Biocare ASA performance evaluation
Checking the ongoing alerts about Hofseth Biocare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hofseth Biocare ASA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Hofseth Biocare ASA generated a negative expected return over the last 90 days | |
| Hofseth Biocare ASA may become a speculative penny stock | |
| Hofseth Biocare ASA has high historical volatility and very poor performance | |
| Hofseth Biocare ASA has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 87.62 M. Net Loss for the year was (126.46 M) with profit before overhead, payroll, taxes, and interest of 28.51 M. | |
| Hofseth Biocare ASA has accumulated about 36.52 M in cash with (61.78 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Roughly 53.0% of the company shares are held by company insiders |
- Analyzing Hofseth Biocare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hofseth Biocare's stock is overvalued or undervalued compared to its peers.
- Examining Hofseth Biocare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hofseth Biocare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hofseth Biocare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hofseth Biocare's stock. These opinions can provide insight into Hofseth Biocare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.